PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

75 hedge funds and large institutions have $70.5M invested in VanEck Pharmaceutical ETF in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 7 closing their positions.

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
18
Reduced
12
Closed
7
Calls
$335K
Puts
$909K
Net Calls
-$574K
Net Calls Change
+$465K

Top Buyers

1
PF
1
Phoenix Financial
Israel
$7.09M
2
LJAC
2
L.J. Altfest & Co
New York
$7.13M
3
SIM
3
Seaview Investment Managers
Florida
$1.86M
4
LSA
4
Lansing Street Advisors
Pennsylvania
$1.7M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$708K

Top Sellers

1
CCP
1
Clough Capital Partners
Massachusetts
$2.77M
2
Citadel Advisors
2
Citadel Advisors
Florida
$967K
3
Osaic Holdings
3
Osaic Holdings
Arizona
$188K
4
Bank of America
4
Bank of America
North Carolina
$2.27M
5
WI
5
Wintrust Investments
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
76
Tower Research Capital (TRC)
New York
– – -7,641 Closed
ASFA
77
All Season Financial Advisors
Colorado
– – -5,184 Closed
MIH
78
Meitav Investment House
Israel
– – -4,895 Closed
AIP
79
Almanack Investment Partners
Pennsylvania
– – -2,782 Closed
ADL
80
Asset Dedication LLC
California
– – -214 Closed
SCA
81
Snowden Capital Advisors
New York
– – -100 Closed
CFGS
82
Concourse Financial Group Securities
Alabama
– – – –
HIA
83
Harbor Investment Advisory
Maryland
$0 2 – –
HNB
84
Huntington National Bank
Ohio
– – – –
1 2 3
4